BGA — BioNeutra Global Share Price
0.000.00%
Last trade - 00:00- CA$2.32m
- CA$9.54m
- CA$11.38m
- 32
- 74
- 24
- 40
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.22 | ||
| EV to EBITDA | 881.96 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -17.28% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 37.7 | 24.12 | 15.4 | 13.39 | 11.38 | n/a | n/a | -21.31% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BioNeutra Global Corporation, through its subsidiaries, is involved in the research, development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on oligosaccharides. The Company’s lead product, VitaFiber IMO, is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. It produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops, including tapioca, field pea or corn into the functional health molecules of isomalto-oligosaccharide. VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. The Company’s customers include a mix of small and medium enterprises.
Directors
- Jianhua Zhu PRE
- Steve Jakeway COO
- Gonglai Yang VPR
- C. H. William Cheung IND
- Curtis Sparrow IND (59)
- William Wei IND
- Stephen Zepp IND
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- March 8th, 1996
- Public Since
- November 5th, 2014
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 46,448,787
- Address
- 9608 - 25 Avenue NW, EDMONTON, T6N 1J4
- Web
- https://www.bioneutra.ca/
- Phone
- +1 7804661481
- Auditors
- Kenway Mack Slusarachuck Stewart LLP
Upcoming Events for BGA
Similar to BGA
Canyon Creek Food
TSX Venture Exchange
CubicFarm Systems
TSX Venture Exchange
Deveron
TSX Venture Exchange
FuelPositive
TSX Venture Exchange
Good Shroom Co
TSX Venture Exchange
FAQ
What is the BioNeutra Global share price?
As of Today at 19:35 UTC, shares in BioNeutra Global are trading at CA$0.05. This share price information is delayed by 15 minutes.
How has the BioNeutra Global share price performed this year?
Shares in BioNeutra Global last closed at CA$0.05 and the price had moved by +66.67% over the past 365 days. In terms of relative price strength the BioNeutra Global share price has outperformed the Toronto Stock Exchange 300 Composite Index by +38.12% over the past year.
What are the analyst and broker recommendations for BioNeutra Global?
There is no consensus recommendation for this security.
Find out moreWhat is the BioNeutra Global dividend yield?
BioNeutra Global does not currently pay a dividend.
Does BioNeutra Global pay a dividend?
BioNeutra Global does not currently pay a dividend.
When does BioNeutra Global next pay dividends?
BioNeutra Global does not currently pay a dividend.
How do I buy BioNeutra Global shares?
To buy shares in BioNeutra Global you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BioNeutra Global?
As of the previous close price of CA$0.05, shares in BioNeutra Global had a market capitalisation of CA$2.32m.
Where are BioNeutra Global shares listed?
Here are the trading details for BioNeutra Global:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: BGA
What kind of share is BioNeutra Global?
Based on an overall assessment of its quality, value and momentum BioNeutra Global is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BioNeutra Global share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the BioNeutra Global share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioNeutra Global. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -61.69%.
As of the last closing price of CA$0.05, shares in BioNeutra Global were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BioNeutra Global PE Ratio?
The BioNeutra Global PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BioNeutra Global?
BioNeutra Global's management team is headed by:
- Jianhua Zhu - PRE
- Steve Jakeway - COO
- Gonglai Yang - VPR
- C. H. William Cheung - IND
- Curtis Sparrow - IND
- William Wei - IND
- Stephen Zepp - IND